TME-SW
01698
XIAOMI-W
01810
BOSS ZHIPIN-W
02076
TENCENT
00700
JD HEALTH
06618
(Q6)Mar 31, 2024 | (FY)Sep 30, 2023 | (Q6)Mar 31, 2023 | (FY)Sep 30, 2022 | (Q6)Mar 31, 2022 | (FY)Sep 30, 2021 | (Q6)Mar 31, 2021 | (FY)Sep 30, 2020 | (Q6)Mar 31, 2020 | (FY)Sep 30, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | 21.49%17.17M | ---- | 160.36%14.13M | ---- | 92.26%-23.41M | ---- | -340.70%-302.51M | ---- | 24.07%-68.64M |
Profit adjustment | ||||||||||
Interest (income) - adjustment | ---- | 85.71%-18K | ---- | 92.69%-126K | ---- | 49.14%-1.72M | ---- | -47.63%-3.39M | ---- | -115.09%-2.3M |
Attributable subsidiary (profit) loss | ---- | 55.10%76K | ---- | --49K | ---- | ---- | ---- | ---- | ---- | ---- |
Impairment and provisions: | ---- | 1.23%-36.63M | ---- | -1,786.49%-37.09M | ---- | -99.14%2.2M | ---- | 469.04%255.35M | ---- | 258.84%44.87M |
-Impairment of property, plant and equipment (reversal) | ---- | 3.18%-20.34M | ---- | ---21.01M | ---- | ---- | ---- | 633.17%132.9M | ---- | --18.13M |
-Impairment of trade receivables (reversal) | ---- | -58.99%750K | ---- | -17.69%1.83M | ---- | -85.25%2.22M | ---- | 6,535.24%15.06M | ---- | --227K |
-Impairment of goodwill | ---- | ---- | ---- | ---- | ---- | -70.38%580K | ---- | -53.46%1.96M | ---- | -47.45%4.21M |
-Other impairments and provisions | ---- | 4.85%-17.04M | ---- | -2,868.99%-17.9M | ---- | -100.57%-603K | ---- | 372.50%105.42M | ---- | 395.82%22.31M |
Revaluation surplus: | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 110.13%399K | ---- | -194.12%-3.94M |
-Other fair value changes | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 110.13%399K | ---- | -194.12%-3.94M |
Asset sale loss (gain): | ---- | 93.62%-9K | ---- | -171.15%-141K | ---- | -101.20%-52K | ---- | --4.33M | ---- | ---- |
-Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | -171.15%-141K | ---- | 96.70%-52K | ---- | ---1.58M | ---- | ---- |
-Loss (gain) on sale of property, machinery and equipment | ---- | ---9K | ---- | ---- | ---- | ---- | ---- | ---4K | ---- | ---- |
-Loss (gain) from selling other assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --5.91M | ---- | ---- |
Depreciation and amortization: | ---- | 27.51%17.2M | ---- | 2.26%13.49M | ---- | -48.40%13.19M | ---- | 19.92%25.56M | ---- | -3.21%21.32M |
-Amortization of intangible assets | ---- | 16.49%3.38M | ---- | 0.80%2.9M | ---- | -55.47%2.88M | ---- | 13.08%6.46M | ---- | -32.75%5.71M |
Financial expense | ---- | 89.05%4.92M | ---- | -38.08%2.6M | ---- | -50.22%4.2M | ---- | 2.96%8.45M | ---- | -68.08%8.2M |
Special items | ---- | -51,350.00%-1.03M | ---- | --2K | ---- | ---- | ---- | 446.15%568K | ---- | -98.67%104K |
Operating profit before the change of operating capital | ---- | 123.74%1.68M | ---- | -26.60%-7.08M | ---- | 50.28%-5.59M | ---- | -2,837.60%-11.25M | ---- | 97.96%-383K |
Change of operating capital | ||||||||||
Inventory (increase) decrease | ---- | 156.47%872K | ---- | 1,788.89%340K | ---- | 104.55%18K | ---- | -424.59%-396K | ---- | 161.62%122K |
Accounts receivable (increase)decrease | ---- | 93.49%-304K | ---- | 0.21%-4.67M | ---- | -305.72%-4.68M | ---- | 89.73%-1.15M | ---- | -56.76%-11.24M |
Accounts payable increase (decrease) | ---- | 138.50%1.93M | ---- | -173.65%-5.02M | ---- | 840.50%6.82M | ---- | -145.66%-921K | ---- | 124.96%2.02M |
prepayments (increase)decrease | ---- | -235.79%-6.9M | ---- | 175.13%5.08M | ---- | -388.11%-6.76M | ---- | --2.35M | ---- | ---- |
Special items for working capital changes | ---- | -94.74%776K | ---- | 3,718.38%14.76M | ---- | -113.68%-408K | ---- | 448.35%2.98M | ---- | 200.00%544K |
Cash from business operations | ---- | -142.19%-3.72M | ---- | 192.53%8.83M | ---- | -13.67%-9.54M | ---- | 6.11%-8.39M | ---- | 74.30%-8.94M |
Other taxs | ---- | -134.09%-1.84M | ---- | 432.41%5.39M | ---- | 101,300.00%1.01M | ---- | 94.44%-1K | ---- | 51.35%-18K |
Interest paid - operating | ---- | 13.29%-150K | ---- | -92.22%-173K | ---- | 58.53%-90K | ---- | ---217K | ---- | ---- |
Special items of business | 55.81%-669K | 132.93%1.79M | -121.13%-1.51M | -407.02%-5.42M | 7,723.40%7.17M | ---1.07M | 99.29%-94K | ---- | 10.69%-13.15M | ---- |
Net cash from operations | 55.81%-669K | -145.54%-3.93M | -121.13%-1.51M | 189.00%8.62M | 7,723.40%7.17M | -12.50%-9.69M | 99.29%-94K | 3.86%-8.61M | 10.69%-13.15M | 74.28%-8.96M |
Cash flow from investment activities | ||||||||||
Interest received - investment | --8K | -96.87%18K | ---- | -72.10%575K | 26,950.00%541K | -62.49%2.06M | -99.77%2K | 201.37%5.49M | -42.95%882K | 93.52%1.82M |
Loan receivable (increase) decrease | ---- | ---- | ---- | -70.88%5M | -79.91%1.3M | 277.56%17.17M | 1,095.38%6.47M | -161.32%-9.67M | -105.34%-650K | 153.57%15.77M |
Sale of fixed assets | -92.59%2K | --28K | --27K | ---- | ---- | ---- | ---- | -98.27%50K | --5K | 142.35%2.88M |
Purchase of fixed assets | 40.60%-3.53M | -59.46%-15.72M | -414.62%-5.95M | -93.07%-9.86M | 60.10%-1.16M | 18.07%-5.11M | ---2.9M | 37.35%-6.23M | ---- | -0.14%-9.95M |
Purchase of intangible assets | ---- | ---292K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Sale of subsidiaries | ---- | ---- | ---- | -140.00%-4K | ---- | -99.30%10K | ---- | --1.43M | --1.43M | ---- |
Acquisition of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 88.87%-760K | ---760K | -4,264.63%-6.83M |
Cash on investment | ---- | ---- | ---- | ---243K | ---- | ---- | ---- | ---- | ---- | ---- |
Other items in the investment business | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 120.07%433K | ---218K | 84.64%-2.16M |
Net cash from investment operations | 40.49%-3.52M | -252.52%-15.96M | -964.53%-5.92M | -132.03%-4.53M | -80.84%685K | 252.71%14.14M | 421.14%3.58M | -699.55%-9.26M | -94.83%686K | 103.02%1.54M |
Net cash before financing | 43.61%-4.19M | -585.90%-19.89M | -194.71%-7.44M | -8.02%4.09M | 125.54%7.85M | 124.91%4.45M | 127.92%3.48M | -141.06%-17.87M | -749.32%-12.47M | 91.37%-7.41M |
Cash flow from financing activities | ||||||||||
New borrowing | -72.25%10.98M | 147.89%57.15M | --39.56M | 196.16%23.05M | ---- | 510.55%7.78M | --3.94M | ---1.9M | ---- | ---- |
Refund | 79.53%-7.69M | 6.51%-15.18M | -836.61%-37.56M | -55.23%-16.23M | 39.07%-4.01M | -366.67%-10.46M | ---6.58M | 18.75%-2.24M | ---- | -16.08%-2.76M |
Issuing shares | ---- | ---- | ---- | ---- | ---- | 192.92%56.26M | ---- | --19.21M | ---- | ---- |
Interest paid - financing | -171.43%-2.68M | -40.94%-3.4M | 34.20%-987K | 49.69%-2.41M | -42.05%-1.5M | -139.96%-4.79M | ---1.06M | -42.24%-2M | ---- | 81.82%-1.4M |
Issuance expenses and redemption of securities expenses | ---- | -19.67%-23.12M | ---- | 37.27%-19.32M | ---- | -313.83%-30.8M | ---3.42M | -2,414.19%-7.44M | ---- | ---296K |
Other items of the financing business | 1.56%4.22M | 215.79%9.67M | 122.48%4.16M | -596.83%-8.35M | -1,040.28%-18.48M | -111.34%-1.2M | -117.31%-1.62M | -37.20%10.57M | 157.76%9.37M | -51.97%16.83M |
Net cash from financing operations | -13.15%3.98M | 195.23%23.83M | 118.27%4.58M | -258.27%-25.02M | -168.25%-25.07M | 15.00%15.81M | -199.77%-9.35M | 11.12%13.75M | 157.76%9.37M | -84.78%12.37M |
Effect of rate | -109.63%-197K | -82.28%446K | 196.97%2.05M | 114.58%2.52M | -134.73%-2.11M | -57.68%1.17M | 38.53%6.08M | 170.50%2.77M | 232.47%4.39M | -2,812.59%-3.93M |
Net Cash | 92.44%-216K | 118.83%3.94M | 83.41%-2.86M | -203.31%-20.93M | -193.61%-17.22M | 591.87%20.26M | -89.10%-5.86M | -183.04%-4.12M | -243.17%-3.1M | 206.97%4.96M |
Begining period cash | 87.78%9.39M | -78.65%5M | -78.65%5M | 1,083.57%23.41M | 1,083.57%23.41M | -40.51%1.98M | -40.51%1.98M | 44.75%3.33M | 44.75%3.33M | -67.51%2.3M |
Cash at the end | 114.28%8.97M | 87.78%9.39M | 2.52%4.19M | -78.65%5M | 86.48%4.08M | 1,083.57%23.41M | -52.49%2.19M | -40.51%1.98M | 300.17%4.61M | 44.75%3.33M |
Cash balance analysis | ||||||||||
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion |
Auditor | -- | -- | -- | -- | -- | -- | -- | Rosenmei Certified Public Accountants | -- | Rosenmei Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.